Literature DB >> 17999066

Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging.

Roy Irwan1, Mireille A Edens, Paul E Sijens.   

Abstract

A recently published Dixon-based MRI method for quantifying liver fat content using dual-echo breath-hold gradient echo imaging was validated by phantom experiments and compared with results of biopsy in two patients (Radiology 2005;237:1048-1055). We applied this method in ten healthy volunteers and compared the outcomes with the results of MR spectroscopy (MRS), the gold standard in quantifying liver fat content. Novel was the use of spectroscopic imaging yielding the variations in fat content across the liver rather than a single value obtained by single voxel MRS. Compared with the results of MRS, liver fat content according to MRI was too high in nine subjects (range 3.3-10.7% vs. 0.9-7.7%) and correct in one (21.1 vs. 21.3%). Furthermore, in one of the ten subjects the MRI fat content according to the Dixon-based MRI method was incorrect due to a (100-x) versus x percent lipid content mix-up. The second problem was fixed by a minor adjustment of the MRI algorithm. Despite systematic overestimation of liver fat contents by MRI, Spearman's correlation between the adjusted MRI liver fat contents with MRS was high (r = 0.927, P < 0.001). Even after correction of the algorithm, the problem remaining with the Dixon-based MRI method for the assessment of liver fat content,is that, at the lower end range, liver fat content is systematically overestimated by 4%.

Entities:  

Mesh:

Year:  2007        PMID: 17999066     DOI: 10.1007/s00330-007-0801-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation.

Authors:  Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Luciano Zenari; Giacomo Zoppini; Giancarlo Falezza
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

3.  Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.

Authors:  Se Hyung Kim; Jeong Min Lee; Joon Koo Han; Jae Young Lee; Kyoung Ho Lee; Chang Jin Han; Jae Young Jo; Nam-Joon Yi; Kyung-Suk Suh; Kyung-Sook Shin; Soo Yeon Jo; Byung Ihn Choi
Journal:  Radiology       Date:  2006-05-09       Impact factor: 11.105

4.  Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.

Authors:  Jürgen Machann; Claus Thamer; Birgit Schnoedt; Norbert Stefan; Hans-Ulrich Haring; Claus D Claussen; Andreas Fritsche; Fritz Schick
Journal:  Magn Reson Med       Date:  2006-04       Impact factor: 4.668

5.  1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.

Authors:  P E Sijens; M J van den Bent; P J Nowak; P van Dijk; M Oudkerk
Journal:  Magn Reson Med       Date:  1997-02       Impact factor: 4.668

6.  Histological characteristics and prognosis in patients with fatty liver.

Authors:  Sanne Dam-Larsen; Maria-Benedicte Franzmann; Per Christoffersen; Klaus Larsen; Ulrik Becker; Flemming Bendtsen
Journal:  Scand J Gastroenterol       Date:  2005-04       Impact factor: 2.423

7.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

8.  Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content.

Authors:  Mirja Tiikkainen; Robert Bergholm; Satu Vehkavaara; Aila Rissanen; Anna-Maija Häkkinen; Marjo Tamminen; Kari Teramo; Hannele Yki-Järvinen
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

9.  Overproduction of large VLDL particles is driven by increased liver fat content in man.

Authors:  M Adiels; M-R Taskinen; C Packard; M J Caslake; A Soro-Paavonen; J Westerbacka; S Vehkavaara; A Häkkinen; S-O Olofsson; H Yki-Järvinen; J Borén
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

Review 10.  Fat in the liver: diagnosis and characterization.

Authors:  Carlos Valls; Ricardo Iannacconne; Esther Alba; Takamichi Murakami; Masatoshi Hori; Roberto Passariello; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2006-02-14       Impact factor: 5.315

View more
  21 in total

1.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

Review 2.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Assessment of relevant hepatic steatosis in obese adolescents by rapid fat-selective GRE imaging with spatial-spectral excitation: a quantitative comparison with spectroscopic findings.

Authors:  Fabian Springer; Stefan Ehehalt; Julia Sommer; Verena Ballweg; Jürgen Machann; Gerhard Binder; Claus D Claussen; Fritz Schick
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

4.  Estimation of proton density fat fraction of the salivary gland.

Authors:  Toru Chikui; Yasuo Yamashita; Yoshitaka Kise; Tomonori Saito; Kazutoshi Okamura; Kazunori Yoshiura
Journal:  Br J Radiol       Date:  2018-02-06       Impact factor: 3.039

5.  The measurement of liver fat from single-energy quantitative computed tomography scans.

Authors:  Xiaoguang Cheng; Glen M Blake; J Keenan Brown; Zhe Guo; Jun Zhou; Fengzhe Wang; Liqiang Yang; Xiaohong Wang; Li Xu
Journal:  Quant Imaging Med Surg       Date:  2017-06

Review 6.  Metabolic syndrome and hepatic resection: improving outcome.

Authors:  Shefali Agrawal; Cherag Daruwala
Journal:  HPB (Oxford)       Date:  2011-10-19       Impact factor: 3.647

7.  Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.

Authors:  Norio Hayashi; Tosiaki Miyati; Takashi Minami; Yumie Takeshita; Yasuji Ryu; Tsuyoshi Matsuda; Naoki Ohno; Takashi Hamaguchi; Kenichiro Kato; Toshinari Takamura; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2012-12-07

8.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

9.  Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods.

Authors:  Gaspard d'Assignies; Martin Ruel; Abdesslem Khiat; Luigi Lepanto; Miguel Chagnon; Claude Kauffmann; An Tang; Louis Gaboury; Yvan Boulanger
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

10.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.